Patents by Inventor CHRISTOPHER DILLON VULPE

CHRISTOPHER DILLON VULPE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Metabolically competent cells, methods of making, and uses thereof
    Patent number: 11932878
    Abstract: Provided herein are genetically engineered cells containing one or more modulated metabolic genes, where the expression of the modulated metabolic gene(s) can be greater than that of an unmodified control. Also provided herein are methods of making the genetically engineered cells using synergistic activation mediator CRISPR-Cas9. Further provided herein are high throughput assays that can employ the genetically engineered cells provided herein.
    Type: Grant
    Filed: July 7, 2017
    Date of Patent: March 19, 2024
    Assignees: University of Florida Research Foundation, Inc., The Research Foundation for the State University of New York
    Inventors: Christopher Dillon Vulpe, Amin Sobh, David Michael Faulkner, Abderrahmane Tagmount, Michael Fasullo
  • METABOLICALLY COMPETENT CELLS, METHODS OF MAKING, AND USES THEREOF
    Publication number: 20190300861
    Abstract: Provided herein are genetically engineered cells containing one or more modulated metabolic genes, where the expression of the modulated metabolic gene(s) can be greater than that of an unmodified control. Also provided herein are methods of making the genetically engineered cells using synergistic activation mediator CRISPR-Cas9. Further provided herein are high throughput assays that can employ the genetically engineered cells provided herein.
    Type: Application
    Filed: July 7, 2017
    Publication date: October 3, 2019
    Inventors: CHRISTOPHER DILLON VULPE, AMIN SOBH, DAVID MICHAEL FAULKNER, ABDERRAHMANE TAGMOUNT, MICHAEL FASULLO